ProMIS Neurosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $129.27 million, with shareholders equity totaling $49.40 million.
The company employs approximately 10 people and operates in the Others sector, within the Others industry.
Over the past 12 months, ProMIS Neurosciences Inc. reported $- in revenue, generating net income of $-39.72 billion.
Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 2.62, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker PMN.